PGP Acted as Exclusive Financial Advisor to Golden Gate Urology in Its Transaction with Unio Specialty Care

Golden Gate Urology has entered into a partnership with Unio Specialty Care in a transaction facilitated by Physician Growth Partners (PGP), marking PGP's tenth engagement in the urology sector. While the deal value remains undisclosed, it underscores the ongoing interest from private equity firms and strategic buyers in scaling high-quality independent physician groups. The announcement was made on July 29, 2026, and highlights the robust market dynamics within the healthcare sector, particularly for urology practices.

Golden Gate Urology operates as a private urology practice in the San Francisco Bay Area, employing 13 physicians across six locations. The practice is dedicated to providing comprehensive evaluation and treatment for a wide range of urologic conditions, utilizing advanced diagnostic and surgical techniques. In contrast, Unio Specialty Care is a multispecialty physician practice that serves over 500,000 patients annually across California. With more than 57 practice locations and a team of over 180 physicians and advanced practice providers, Unio is well-positioned as a leader among independent, community-based healthcare providers.

The strategic rationale behind this partnership is to leverage the strengths of both organizations to enhance patient care and expand service offerings. The collaboration is expected to create synergies that will allow Golden Gate Urology to access a broader patient base and enhance its operational capabilities. As the healthcare landscape evolves, the ability to provide comprehensive services under one umbrella is increasingly important, particularly in a state like California, where regulatory complexities can pose challenges to independent practices.

The transaction also reflects broader trends within the healthcare sector, where investor appetite for independent physician groups remains strong. The urology market is benefiting from favorable demographic trends, increasing demand for ancillary services, and the necessity for practices to scale in order to remain competitive. As noted by Robert Aprill, Partner at PGP, the ongoing demand for quality urology practices is evident, even in highly regulated markets. This partnership is indicative of the potential for exceptional physician groups to achieve favorable outcomes, regardless of geographic challenges.

Looking ahead, the implications of this transaction may signal a continued consolidation trend within the healthcare sector, particularly among independent physician practices. As private equity and strategic buyers seek to invest in high-quality healthcare providers, the focus on scalability and comprehensive service offerings is expected to drive further M&A activity. This partnership between Golden Gate Urology and Unio Specialty Care may serve as a blueprint for future transactions in the healthcare space, highlighting the importance of strategic alliances in navigating an increasingly complex regulatory environment while delivering high-quality patient care.